{"id":"W4206112747","doi":"10.1007/s13555-021-00679-6","title":"Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study","year":2022,"lang":"en","type":"article","venue":"Dermatology and Therapy","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University; Queen Elizabeth II Health Sciences Centre","funders":"Celgene; Eli Lilly and Company; AbbVie; Bristol-Myers Squibb; Amgen","keywords":"Medicine; Psoriasis Area and Severity Index; Secukinumab; Internal medicine; Body mass index; Psoriasis; Disease; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004463048,0.001185582,0.005335006,0.0006317797,0.0002650814,0.00120535,0.0006754449,0.001050844,0.001651228],"category_scores_gemma":[0.004969222,0.0004195959,0.01052863,0.0007208696,0.0003155885,0.0006178127,0.000619937,0.001416105,0.0002269386],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004482135,"about_ca_system_score_gemma":0.0006913622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008635543,"about_ca_topic_score_gemma":0.002375685,"domain_scores_codex":[0.9972946,0.001262611,0.000507935,0.0003562543,0.0002821807,0.0002964005],"domain_scores_gemma":[0.9976776,0.001063293,0.0004801904,0.0003778465,0.0001737604,0.000227258],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7898362,0.00111206,0.08391018,0.002183037,0.07336377,0.0004919831,0.0003267242,0.002174206,0.006554471,0.0002159715,0.002519254,0.03731222],"study_design_scores_gemma":[0.248087,0.09279692,0.4931337,0.0007925794,0.1392389,0.001500096,0.001074319,0.008342691,0.003689251,0.002164545,0.00885151,0.0003286189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9849908,0.01086927,0.0005860217,0.0002777347,0.0001871444,0.0005484029,0.001563032,0.00003337063,0.0009442357],"genre_scores_gemma":[0.9948114,0.00138926,0.000402085,0.0003664437,0.0001879212,0.000572364,0.001899819,0.00001697287,0.0003537214],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005335006,"threshold_uncertainty_score":0.02360314,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01272238365555321,"score_gpt":0.2317351978191852,"score_spread":0.2190128141636319,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}